Dublin, March 13, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Antifungal Drugs: Technologies and Global Markets" report to their offering. The aim of this report is to initially conduct a review of the antifungal drugs currently available, the issues facing the use of antifungal drugs and review some of the latest developments of new and innovative antifungal drugs, their technologies, and their intended clinical applications. The key objective was also to conduct and provide an analysis of the market value, growth rates, market shares, market development as well as examining the market dynamics and market factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry, and the factors influencing the market shares of the major market suppliers as well as smaller indigenous manufactures in local markets. The emphasis of this report is to provide the reader with: A detailed analysis of the revenues and forecasts for the global antifungal drugs market with a further more detailed analysis and forecast of the revenues for the global market sub-divided by major market sub-segments by geographic region and finally by selected country. A detailed analysis of the global market share together with a further more detailed analysis of the market share by geographic regions and finally by selected country.
Report Includes
- An overview of the global market for antifungal drugs.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Identification of new antifungal research, development, and drug applications.
- Heavy focus on therapeutics in early development such as new molecular and biological entities from traditional pharmaceutical sources, naturally derived synthetic chemicals, and biological sources.
- Information on over the counter (OTC) vs. prescription products.
Profiles of major players in the industry
- Ferrer Internacional S.A.
- Enzon Pharmaceuticals Inc.
- Astellas Pharma Inc.
- Galderma Pharma SA Galderma SA
- Gilead Sciences Inc.
- Glenmark Pharmaceuticals Limited
- Sigma-Tau Pharma-ceuticals Inc.
- TEVA Pharmaceuticals Industries Ltd.
- Valeant Pharmaceuticals International Inc.
- Dartmouth Pharmaceuticals.
Key Topics Covered: 1: Introduction - Introduction To The Report - Reasons For Doing This Study - Scope - Methodology 2: Executive Summary - Market Segmentation 3: Introduction To The Global Antifungal Drug Market - Scope Of Applications: Human Healthcare - Primary Fungal Infections - Opportunistic Fungal Infections - Human Fungal Infections - Selection Of Statistical Data On Fungal Infections - Fungal Infection Of The Nails - Risk Factors For Developing Fungal Infections - Fungal Species That Cause Infection In Humans 4: Common Environmental Fungi - Molds And The Human Issues Associated With Them - Why Environmental Mold Is A Unique Problem - Health Risks Due To Environment Fungi And Mold - Environmental Molds 5: Antifungal Agents - Antifungal Agents - Classification Of Anti Fungal Agents - Systemic Antifungal Drugs - Azoles - Echinocandins - Antimetabolite: Flucytosine (5-Fc) - Other Systemic Antifungal Agents - Topical Antifungal Drugs - Others 6: Summary: Global Market For Antifungal Drugs - Introduction - Market Revenue Analysis 7: North American Market For Antifungal Drugs - Regulatory And Legislative Requirements - Market Dynamics - Market Revenue Analysis - Market Share Analysis 8: European Market For Antifungal Drugs - Regulatory And Legisative Requirements: Europe - The Russian Federation - Market Dynamics - Market Revenue Analysis - Market Share Analysis 9: Asia-Pacific Market For Antifungal Drugs - Japan - China - India - South Korea - Market Dynamics - Market Revenue Analysis - Market Share Analysis 10: Latin America Market For Antifungal Drugs - Brazil - Argentina - Mexico - Market Dynamics - Market Revenue Analysis - Market Share Analysis 11: Middle East/Africa Market For Antifungal Drugs - Introduction - South Africa - Saudi Arabia - Market Dynamics - Market Revenue Analysis - Market Share Analysis 12: Company Profiles - Manufacturers Of Prescription Pharmaceuticals - Otc Antifungal Manufacturers - Pharmaceutical Otc Market - Alternative Otc Manufacturers - Major Alternative Otc Manufacturer Profiles 13: Appendixes 14: Government Regulatory Agencies And Professional Associations - Government Regulations - Food And Drug Administration (Fda) - Environmental Protection Agency (Epa) - United States Department Of Agriculture (Usda) - Food And Agricultural Organization Of The United Nations - Professional Associations For more information about this report visit http://www.researchandmarkets.com/research/vn...ngal_drugs
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Over the Counter (OTC) Drugs
